WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 1390

Legislative bill overview

HB 1390 relates to the medical use of cannabis in Hawaii, though the specific provisions are not detailed in the available action history. The bill was introduced in January 2025, passed first reading, and was referred to multiple committees (Health, Judiciary/Criminal, and Finance) before being carried over to the 2026 legislative session.

Why is this important

Medical cannabis legislation affects patient access to alternative treatments, regulatory frameworks for dispensaries, healthcare provider protocols, and state tax revenue. Hawaii already has an established medical cannabis program, so this bill likely addresses modifications, expansions, or refinements to existing policy rather than creating a new program.

Potential points of contention

  • Scope of qualifying conditions: Disagreement over which medical conditions should qualify patients for medical cannabis access
  • Regulatory and licensing requirements: Debates about how strict regulations should be for growers, processors, and dispensaries
  • Workplace and driving safety: Concerns about impairment testing, employee protections, and public safety standards related to cannabis use
  • Federal-state conflict: Tension between Hawaii state law and federal cannabis prohibition, affecting banking and interstate commerce
  • Tax implications and pricing: Questions about appropriate tax rates and their effect on program affordability and illegal market competition

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.